263 related articles for article (PubMed ID: 22017010)
21. [SREBP-1c knockdown attenuated fatty degeneration in hepatic L02 cells and inhibited CCL2 and FGF21 protein expression].
Wang WD; Wang J; Fan LL; Xiong J; Sun WJ; Hu L; Yang L; Chen DF
Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):664-9. PubMed ID: 22152380
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.
McPherson S; Jonsson JR; Barrie HD; O'Rourke P; Clouston AD; Powell EE
J Hepatol; 2008 Dec; 49(6):1046-54. PubMed ID: 18752865
[TBL] [Abstract][Full Text] [Related]
23. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
[TBL] [Abstract][Full Text] [Related]
24. [Diosgenin alleviates NAFLD induced by a high-fat diet in rats via mTOR/SREBP-1c/HSP60/MCAD/SCAD signaling pathway].
Chen SW; Yin GL; Song CY; Meng DC; Yu WF; Zhang X; Feng YN; Liang PP; Zhang FX
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5304-5314. PubMed ID: 38114120
[TBL] [Abstract][Full Text] [Related]
25. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
26. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.
Aragno M; Tomasinelli CE; Vercellinatto I; Catalano MG; Collino M; Fantozzi R; Danni O; Boccuzzi G
Free Radic Biol Med; 2009 Oct; 47(7):1067-74. PubMed ID: 19616615
[TBL] [Abstract][Full Text] [Related]
27. [The role of adiponectin and adiponectin receptor 2 in the pathology of fatty liver].
Li HS; Feng Q; Hu YY; Chen SD; Peng JH; Li XM; Xu LL
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):826-30. PubMed ID: 19958641
[TBL] [Abstract][Full Text] [Related]
28. Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats.
Gong XW; Xu YJ; Yang QH; Liang YJ; Zhang YP; Wang GL; Li YY
Chin J Integr Med; 2019 Mar; 25(3):216-224. PubMed ID: 29335857
[TBL] [Abstract][Full Text] [Related]
29. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
30. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
[TBL] [Abstract][Full Text] [Related]
31. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
32. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Fbxw7 expression and its correlation with expression of SREBP-1 in a mouse model of NAFLD.
Tu K; Zheng X; Yin G; Zan X; Yao Y; Liu Q
Mol Med Rep; 2012 Sep; 6(3):525-30. PubMed ID: 22710480
[TBL] [Abstract][Full Text] [Related]
34. [Effect of Hovenia dulcis extract on expression of MMP-13 and TIMP-1 in hepatic tissue].
Liu XL; Zhnag H; Wang F
Zhongguo Zhong Yao Za Zhi; 2006 Jul; 31(13):1097-100. PubMed ID: 17048613
[TBL] [Abstract][Full Text] [Related]
35. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
[TBL] [Abstract][Full Text] [Related]
36. Effects of different therapeutic methods and typical recipes of Chinese medicine on activation of c-Jun N-terminal kinase in kupffer cells of rats with fatty liver disease.
Yang QH; Hu SP; Zhang YP; Ping HH; Yang HW; Chen TY; Liu HT
Chin J Integr Med; 2012 Oct; 18(10):769-74. PubMed ID: 22965700
[TBL] [Abstract][Full Text] [Related]
37. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice.
Murase T; Misawa K; Minegishi Y; Aoki M; Ominami H; Suzuki Y; Shibuya Y; Hase T
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E122-33. PubMed ID: 20943752
[TBL] [Abstract][Full Text] [Related]
38. [Effects of puerarin on expressions of leptin receptor mRNA, phosphorylated Janus kinase 2/phosphorylated signal transducers and activators of transcription 3 proteins in the liver of rats with non-alcoholic fatty liver].
Zheng PY; Ma ZS; Hua YQ; Liu T; Xing LJ; Ji G
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):921-7. PubMed ID: 18782535
[TBL] [Abstract][Full Text] [Related]
39. [Effect of total alkaloids of Rubus alceaefolius on oxidative stress in rats with non-alcoholic fatty liver disease].
Zheng H; Zhao J; Liu Y; Zheng Y; Wu J; Hong Z
Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(17):2383-7. PubMed ID: 22121808
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of SREBP-1c is associated with the development of burned-out NASH.
Nagaya T; Tanaka N; Suzuki T; Sano K; Horiuchi A; Komatsu M; Nakajima T; Nishizawa T; Joshita S; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Nakayama J; Tanaka E; Aoyama T
J Hepatol; 2010 Oct; 53(4):724-31. PubMed ID: 20655124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
